Arturo LoAIza-Bonilla: Bringing AI and technology to the forefront of oncology clinical trials at scale
Arturo LoAIza-Bonilla, Co-Founder and Chief Medical Officer of Massive Bio and Medical Director of Oncology Research at Capital Health (US), shared a post on LinkedIn:
”Exciting times in Boston! Both Selin Kurnaz and I are bringing AI and technology to the forefront of oncology clinical trials at scale. At the Digital Health and AI Innovation Summit (DHAI), I’ll be sharing insights on how AI-powered networks and precision oncology are transforming clinical trial enrollment. Meanwhile, Selin will be at the Oncology Venture, Innovation and Partnering (VIP) Summit discussing how AI adds value in oncology, from discovery to care delivery. Also some exciting news about our collaborative approach to tackle this at Massive Bio!
Together, we’re making collaboration in healthcare innovation a reality. Our focus is clear—delivering cutting-edge solutions through AI and scaling access to oncology clinical trials like never before.
Join us and be part of the conversation that’s shaping the future of cancer care!
DHAI: October 9-10, 2024.
Oncology VIP Summit: October 9-10, 2024.”
Source: Arturo LoAIza-Bonilla/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023